Ideas for Medicine recall
This article was originally published in The Gray Sheet
Executive SummaryClass II recall involves only the Reddick-Saye screw modification, not the Grice Abdominal Lift, which is a separate device, the company says in a July 26 letter to "The Gray Sheet". FDA's June 15 Enforcement Report listed a recall of the firm's "Grice Abdominal Lift Reddick-Saye screw modification" ("The Gray Sheet" June 20, p. 11)
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.